260 related articles for article (PubMed ID: 21777216)
1. The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.
Abuabara K; Lee H; Kimball AB
Br J Dermatol; 2011 Nov; 165(5):1066-73. PubMed ID: 21777216
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.
Ahlehoff O; Skov L; Gislason G; Lindhardsen J; Kristensen SL; Iversen L; Lasthein S; Gniadecki R; Dam TN; Torp-Pedersen C; Hansen PR
J Intern Med; 2013 Feb; 273(2):197-204. PubMed ID: 22963528
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
Ahlehoff O; Skov L; Gislason G; Gniadecki R; Iversen L; Bryld LE; Lasthein S; Lindhardsen J; Kristensen SL; Torp-Pedersen C; Hansen PR
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1128-34. PubMed ID: 25303139
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
Feldman SR; Evans C; Russell MW
J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
[TBL] [Abstract][Full Text] [Related]
5. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
Kaye JA; Li L; Jick SS
Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
[TBL] [Abstract][Full Text] [Related]
6. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.
Chen YJ; Wu CY; Chen TJ; Shen JL; Chu SY; Wang CB; Chang YT
J Am Acad Dermatol; 2011 Jul; 65(1):84-91. PubMed ID: 21458106
[TBL] [Abstract][Full Text] [Related]
7. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of myocardial infarction in patients with psoriasis in central China.
Xiao J; Chen LH; Tu YT; Deng XH; Tao J
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1311-5. PubMed ID: 19522710
[TBL] [Abstract][Full Text] [Related]
9. Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis.
Scherrer JF; Virgo KS; Zeringue A; Bucholz KK; Jacob T; Johnson RG; True WR; Carney RM; Freedland KE; Xian H; Caplan L; McDonald J; Eisen SA
Gen Hosp Psychiatry; 2009; 31(4):353-9. PubMed ID: 19555796
[TBL] [Abstract][Full Text] [Related]
10. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
[TBL] [Abstract][Full Text] [Related]
11. Coronary heart disease outcomes in patients receiving antidiabetic agents.
McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
13. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
[TBL] [Abstract][Full Text] [Related]
14. Risk of Herpes zoster in patients with psoriasis treated with biologic drugs.
Dreiher J; Kresch FS; Comaneshter D; Cohen AD
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1127-32. PubMed ID: 21923837
[TBL] [Abstract][Full Text] [Related]
15. Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate.
van de Kerkhof P; Griffiths CE; Christophers E; Lebwohl M; Krueger GG
Dermatology; 2005; 211(3):256-63. PubMed ID: 16205071
[TBL] [Abstract][Full Text] [Related]
16. A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.
Fonia A; Jackson K; Lereun C; Grant DM; Barker JN; Smith CH
Br J Dermatol; 2010 Oct; 163(4):807-16. PubMed ID: 20662837
[TBL] [Abstract][Full Text] [Related]
17. Significant delay in the introduction of systemic treatment of moderate to severe psoriasis: a prospective multicentre observational study in outpatients from hospital dermatology departments in France.
Maza A; Richard MA; Aubin F; Ortonne JP; Prey S; Bachelez H; Beylot-Barry M; Bulai-Livideanu C; Lahfa M; Nougué J; Mengual X; Le Moigne M; Lauwers-Cances V; Paul C
Br J Dermatol; 2012 Sep; 167(3):643-8. PubMed ID: 22512545
[TBL] [Abstract][Full Text] [Related]
18. Do TNF inhibitors reduce the risk of myocardial infarction in psoriasis patients?
Armstrong AW
JAMA; 2013 May; 309(19):2043-4. PubMed ID: 23677316
[TBL] [Abstract][Full Text] [Related]
19. Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.
Shalom G; Zisman D; Bitterman H; Harman-Boehm I; Greenberg-Dotan S; Dreiher J; Feldhamer I; Moser H; Hammerman A; Cohen Y; Cohen AD
JAMA Dermatol; 2015 May; 151(5):533-8. PubMed ID: 25797026
[TBL] [Abstract][Full Text] [Related]
20. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.
Shapiro J; Cohen AD; David M; Hodak E; Chodik G; Viner A; Kremer E; Heymann A
J Am Acad Dermatol; 2007 Apr; 56(4):629-34. PubMed ID: 17157411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]